Pharmacology Flashcards

1
Q

Causes of a reverse hysteresis loop

A

Secondary messengers
Prodrug–>Active metabolite
Redistribution phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

amantadine

A

NMDA receptor antagonist
used in dyskinesias in PD
fatigue in MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

rivaroxaban

A

Xa inhibitor
Cmax 4 hours; good oral bioavailability
irreversible
inhibits both extrinsic and intrinsic pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the interaction between verapamil and digoxin

A

raised digoxin levels due to non competitive inhibition of p glycoprotein in renal tubules leading to decreased renal secretion. biliary clearance is also reduced.
also display synergism in their effects on heart rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

which antibiotics inhibit cell wall synthesis

A

beta lactams, glycopeptides, cyclosporin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

which antibiotics inhibit protein synthesis

A

aminoglycosides, tetracyclines
chloramphenicol, clindamycin, macrolides, fusidic acid, linezolid aicd
mupirocin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

which antibiotics inhibit nucleic acid synthesis or activity

A

folic acid: trimethoprim, sulphonamides
DNA gyrase; fluoroquinolones
RNA polymerase: rifampicin
DNA: nitrofurantoin, metronidazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

GWAS

A

looks at entire genome of a population to find SNPs a/w traits
huge likelihood of random associations - need to do bonferoni correction to control for this
hardy weinberg equilibrium aims to eliminate selection bias (alleles should be equal between all individuals)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

bioavailability

A

F = AUC oral / AUC IV

AUC o / dose o) / (AUC iv / dose iv

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

hepatic extraction ratio

A

HER = 1 - bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Volume of distribution

A

Vod = dose / concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

loading dose for desired concentration

A

loading dose = Vod x concentration steady state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

clearance

A

Cl = amount of body fluid cleared of substance per unit time
Cl = L / h
does not depend on concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

zero order kinetics

A

a set amount of drug is eliminated per unit time

slow plug away at sobering up from a big night regardless of how drunk you were

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

first order kinetics

A

a set proportion of drug is eliminated per unit time
increased elimination with increased concentration

(c/w clearance which does not depend on concentration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

albumin

A

binds acid drugs; other acids will compete for binding

eg: salicylic acid, warfarin, penicillins, sulphonamides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

alpha1 acid glycoprotein

A

binds basic drugs

eg: propranolol, quinidine, impramine, lignocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

dialysis

A

does not affect highly protein bound drugs

or drugs with high VoD (as they are not in the blood)

19
Q

adjusting dose for renal impairment

A

(1-fu) + (fu x % renal fx remaining)

% renal fx = CrCl/1.5

20
Q

maintenance dose

A

maintenance dose or infusion rate = clearance x steady state drug concentration

21
Q

half life

A

t1/2 = 0.7 X Vd/Cl

22
Q

VoD

A

VoD = dose / peak plasma concentration

assume peak plasma concentration occurs 1 hour post IV infusion

23
Q

how do you increase excretion of an acid drug

A

alkalinise the urine

eg: salicylate overdose

24
Q

EC50

A

concentration of drug to give half maximal response

Emax is maximal effect (obtained when all receptors are occupied by the drug)

25
therapeutic index
TI = adverse effect EC50/ therapeutic effect EC50
26
tachyphylaxis
need greater concentration for same effect ie: down regulation of receptors eg: cocaine
27
antagonists
competitive: need increased concentration to achieve effect as competing for the same receptors (curve moves right) non competitive: irreversible binding to receptor so will decrease maximum effect (curve moves down)
28
lithium
SEs: hypothyroid, hyperparathyroid, reduced renal tubular fx toxicity: acute - GI - N, V, D chronic - neurological - ataxia, tremor, confusion increased QTc toxicity worsened by hypovolaemic states as Li is treated like Na+ in the kidney Rx with IVT, very dialysable short half life
29
raloxifene
SERM; used for osteoporosis CI if hx of DVT / PE increases stroke risk if RFxs increases hot flashes
30
digoxin
toxicity: visual change - esp colour confusion nausea, vomiting, abdominal pain
31
carbamazepine
Stevens Johnson Syndrome esp if HLA B1502
32
cetuximab
EGFR inhibitor k ras wild type (does not work with k ras mutant) CRC, adeno lung, SCC head and neck
33
dabigatran
direct thrombin inhibitor prodrug indications: DVT prophylaxis post ortho surgery DVT treatment, non valvular AF CI: pregnancy, CrCl < 30 interactions: rifampicin, verapamil, amiodarone, ketoconazole, quinidine, tacrolimus, cyclosporin, clarithromycin monitor TCT; evidece for increased MI 150mg BD increased GI bleed less ICH than warfarin prothrombinex if life threatening bleeding
34
CYP2D6
``` poor metabolisers 10% cauc ineffective codeine (prodrug) systemic timolol toxic perhexiline cannot metabolise propranolol, quinidine avoid inhibitors (SSRIs) when on tamoxifen as tamoxifen is metabolised to active form by 2D6 substrates: tramadol ```
35
CYP2C9
poor metabolisers 1-3% | 1mg warfarin
36
CYP2C19
poor metabolisers 20% asians | reduced clearance omeprazole
37
acetylation
slow: procainamide, hydralazine --> SLE | isoniazid --> peripheral neuropathy is slow; hepatitis if fast
38
p glycoprotein substrates
``` terfenadine, fexofenadine digoxin daunorubicin, doxorubicin, etoposide, paclitaxel, vinblastine, vincristine colchicine ritonavir ciclosporin ivermectin, loperamide aldosterone, hydrocortisone, dexamethasone, progesterone ,estrogen ```
39
potency
``` potency ED50 (point of x axis where half way) efficacy is Emax (height) ```
40
erlotinib
TKI for lung, pancreatic CA - CYP1A1 metabolism - induced by smoking; need higher doses
41
CYP3A4
substrates tramadol, docetaxel, etoposide, irinotecan, imatinib, vincristine, aprepitant, pred inhibitors: aprepitant, ketoconazole, ciprofloxacin, clarithromycin, ritonavir, verapamil, quinidine inducers: phenobarbitone, phenytoin, rifampicin
42
avoid in pregnancy
``` mycophenolate - both mum and dad leflunomide - washout prior to conception methotrexate sirolimus / everolimus efavirenz ```
43
renal maintenance
induction: cyclophosphamide maintenance: aza for ANCAs; MMF for SLE
44
tamsulosin
1a alpha blocker